Skip to main content

Table 3 The Response Rate in the Trial and Control Group for Different Type of Tumors

From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

  Group n CR PR MR SD PD Response rate p*
NSCLC Trial 17 1 7 3 4 2 47.06% (8/17) 0.208
  Control 6 0 1 1 3 1 16.67% (1/6)  
Gastric cancer Trial 32 0 4 6 13 9 12.50% (4/32) 0.283
  Control 18 0 0 2 9 7 0.00 (0/18)  
Colorectal cancer Trial 20 0 1 2 10 7 5.00% (1/20) 1.000
  Control 12 0 0 1 7 4 0.00 (0/12)  
  1. *The p value is calculated by Fisher exact chi-square because n < 30 or some cells have expected count less than 1.